Quick Facts

• Visceral fat around organs is a stronger predictor of disease risk than BMI or total weight
• New AI research shows hidden belly fat accelerates heart aging while hip and thigh fat may protect women
• Studies link visceral fat to 77% of amyloid buildup in the brain, increasing Alzheimer’s risk

Hidden belly fat wrapped around your organs poses greater health risks than the number on your scale, according to groundbreaking research using artificial intelligence to analyze over 21,000 participants.

Scientists discovered that visceral fat – the deep abdominal fat surrounding organs like the liver and intestines – accelerates heart aging and brain deterioration. This type of fat makes up only 10% of total body fat in most people but drives the majority of metabolic disease risk.

The 2025 study using MRI imaging found visceral fat speeds up cardiovascular aging while fat stored around hips and thighs may actually protect women’s hearts. Even more concerning, separate research shows this hidden fat accounts for 77% of amyloid protein buildup in the brain – a hallmark of Alzheimer’s disease.

Normal Weight, Hidden Danger

Up to 25% of people have “normal weight obesity” – appearing healthy on the outside while carrying dangerous levels of visceral fat. These individuals face the same disease risks as people classified as obese by BMI standards.

Dr. David Kessler, former FDA commissioner, explained that visceral fat “leeches fatty acids called adipokines or chemokines, which cause systemic inflammation in the body.” This inflammation drives higher blood pressure, blood sugar spikes, and unfavorable cholesterol levels.

Women with the largest waists relative to hip size were twice as likely to develop heart disease. Otherwise healthy women experienced a 10% increase in heart disease risk for every 2-inch increase in waist size.

Measurement Matters More Than Weight

Waist measurements provide better health predictions than BMI. Women with waists measuring 35 inches or more and men with 40 inches or more face increased health risks, regardless of their weight.

Professor Bryan Williams of the British Heart Foundation stated: “We already know excess visceral fat around the heart and liver can lead to increased blood pressure and high cholesterol, so it is concerning that it could also help to speed up aging of the heart and blood vessels.”

DEXA scans offer the most practical gold-standard measurement for visceral fat, correlating well with more expensive CT and MRI imaging.

New Treatment Options Show Promise

GLP-1 medications like semaglutide specifically target visceral fat through both appetite control and metabolic enhancement. A 2023 analysis of 30 studies with 1,738 participants found these drugs substantially reduce visceral fat and liver fat content.

Recent trials combining bimagrumab with semaglutide showed 92.8% of weight loss came from fat mass, with greater reductions in visceral fat and inflammation markers compared to single treatments.

Lifestyle changes remain the foundation of visceral fat reduction. Building muscle mass while losing fat offers protective effects, with research showing more muscle tissue correlates with younger-looking brains and better metabolic health.

Read more: This ‘Hidden’ Body Fat May Matter More Than Your Weight